Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,811
Closed -$1.95M 1356
2026
Q1
$1.95M Buy
+25,811
New +$1.94M 0.05% 296
2025
Q4
Sell
-32,534
Closed -$2.2M 1385
2025
Q3
$2.2M Buy
+32,534
New +$2.16M 0.03% 213
2024
Q2
Sell
-25,691
Closed -$2M 1172
2024
Q1
$2M Buy
+25,691
New +$1.91M 0.04% 255
2023
Q4
Sell
-15,380
Closed -$1.07M 1129
2023
Q3
$1.07M Buy
15,380
+10,822
+237% +$818K 0.03% 342
2023
Q2
$369K Sell
4,558
-10,572
-70% -$864K 0.01% 626
2023
Q1
$1.22M Sell
15,130
-4,864
-24% -$392K 0.04% 437
2022
Q4
$1.5M Buy
+19,994
New +$1.42M 0.05% 387
2022
Q2
Sell
-17,063
Closed -$1.31M 1118
2022
Q1
$1.31M Buy
17,063
+13,190
+341% +$949K 0.05% 218
2021
Q4
$296K Buy
+3,873
New +$285K 0.01% 331

Other funds holding HOLX

Graham Capital Management's HOLX Position: Q2 2026 in Review

Graham Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 25,811 shares — an estimated $1.95M sold.

Graham Capital Management first reported a position in HOLX in Q4 2021 and held it in 9 quarters. The position peaked at $2.2M in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Graham Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 25,811 Hologic shares in Q2 2026, an estimated $1.95M.
  • Graham Capital Management first reported a position in Hologic in Q4 2021 and held it in 9 quarters.
  • Graham Capital Management's Hologic position peaked at $2.2M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.